Guidelines: COVID-19 Drug Therapy Trial Updates
Guideline Resources
COVID-19 Drug Therapy Trial Updates
Key Points
Updated 4/7/20. No drug is currently FDA-approved to treat COVID-19. The FDA recently approved an NIH "adaptive" randomized clinical trial of investigational therapeutics for hospitalized COVID-19 pts; the investigational drug remdesivir is the 1st therapeutic w/in this trial. Existing drugs that are FDA-approved for other uses are also being studied in COVID-19 pts. Note: Links lead to trial details at

Stay current on CDC's latest COVID-19 guidance w/ epocrates COVID-19 decision tool.
Choose Trial Update
Epocrates researched Rx drug content. Peer-reviewed.
Epocrates Guideline Synopsis Last Update: Apr 7, 2020
Publication Year:
COVID-19coronavirus dz 2019
RCTrandomized controlled trial